Loading...

Home
ETF
ANIX

ANIX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ANIX News

Anixa Biosciences Reports Positive Clinical Trial Results for Cancer Vaccines

Apr 09 2026PRnewswire

Anixa Biosciences Reports Progress on Cancer Vaccine Trials

Apr 09 2026Newsfilter

Anixa Biosciences Advances Cancer Immunotherapy Pipeline

Apr 06 2026PRnewswire

Anixa Biosciences Advances Cancer Immunotherapy Pipeline

Apr 06 2026Newsfilter

Anixa Biosciences Advances Breast Cancer Vaccine Clinical Trial Following Phase 1 Success

Apr 01 2026PRnewswire

Anixa Biosciences Advances Cancer Therapy with Lira-cel Trial Update

Mar 30 2026PRnewswire

Anixa Biosciences Updates on CAR-T Therapy Progress

Mar 30 2026Newsfilter

Anixa Biosciences CEO Discusses Cancer Vaccine Progress on Podcast

Mar 12 2026Newsfilter

Anixa Biosciences CEO Discusses Cancer Vaccine Progress on Podcast

Mar 12 2026PRnewswire

Anixa Biosciences Secures Patent Allowance in South Korea

Mar 09 2026seekingalpha

Anixa Secures Korean Patent for Breast Cancer Vaccine

Mar 09 2026PRnewswire

Anixa Biosciences to Host 2026 Annual Stockholders Meeting

Mar 02 2026PRnewswire

Anixa Biosciences to Host 2026 Annual Stockholders Meeting

Mar 02 2026Newsfilter

Anixa Biosciences Updates on Ovarian Cancer CAR-T Trial Outcomes

Feb 09 2026Benzinga

Anixa Biosciences' CAR-T Therapy Receives Naming Approval

Feb 02 2026PRnewswire

Anixa Biosciences CAR-T Therapy Receives Naming Approval

Feb 02 2026Newsfilter